The Development of Sarcoidosis in an Ulcerative Colitis Patient Treated with Vedolizumab: A Case Report and Review of the Literature
The coexistence of UC and sarcoidosis during vedolizumab therapy is rare. Although causality cannot be established, our findings suggest that vedolizumab may be safely continued in selected patients under close multidisciplinary monitoring.
Authors
- Αpostolos Papalois (ORCID: https://orcid.org/0000-0001-8339-7426)
- Victoria Polydorou
- John K. Triantafillidis (ORCID: https://orcid.org/0000-0002-9115-232X)
- Manousos Konstantoulakis
- Kostas Pantos
- Loukas Kaklamanis
- Konstantinos Malgarinos
- Emmanouil Kritsotakis
- Agni Pantou
- Konstantinos Sfakianoudis
- Konstantinos Bramis
Institutions
- National and Kapodistrian University of Athens (GR)
- European University Cyprus (CY)
- Senologic Hellenic Society (GR)
- Onassis Cardiac Surgery Center (GR)
- Metropolitan Hospital (GR)
- Center for Human Reproduction (US)
Publication Details
- Journal
- Clinics and Practice
- Published
- 2026-02-23
- DOI
- https://doi.org/10.3390/clinpract16020044
- Primary Topic
- Sarcoidosis and Beryllium Toxicity Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00